Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
Clinical trial NCT03308396 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03308396
- Sponsor
- Ajjai Alva, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2022-12-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.